新肿瘤标志物—长链非编码RNA分子机制及其与肿瘤关系研究进展

doi:10.3969/j.issn.1009-976X.2015.06.026

摘要/Abstract

摘要： 【摘要】〓长链非编码RNA(LncRNA)具有复杂的生物学功能,在多种类型恶性肿瘤组织中表达异常,影响肿瘤细胞的增殖、迁移、侵袭等能力,对肿瘤发生、发展起促进或抑制作用。本文将对LncRNA调控基因表达的分子机制以及与肿瘤关系进展予以综述,为进一步研究LncRNA作为诊断、治疗、预后的新肿瘤标志物奠定基础。

关键词: 癌症, 长链非编码RNA, 基因调控, 肿瘤标志物

Abstract: 【Abstract】〓Long non coding RNAs have been showed to regulate gene expression in diverse processes. Expression of lncRNAs are deregulated in kinds of human cancers. They affect cancer cell proliferation, migration, and invasion, promote or inhibit the development and metastasis of cancers. In this review we summarized the molecular mechanisms of LncRNAs and outlined the current state of knowledge about the application of lncRNAs as tumor biomarkers.

Key words: Gene expression regulation, Cancer, Tumor biomarkers　, Long non coding RNA

中图分类号:

R739.7

黄楚媚曾林涓苏红黄开红. 新肿瘤标志物—长链非编码RNA分子机制及其与肿瘤关系研究进展[J]. 岭南现代临床外科, 2015, 15(06): 743-748.

Huang Chumei, Zeng Linjuan, Su Hong, Huang Kaihong. Molecular mechanisms and development in human cancers of Long noncoding RNAs:.A potential novel class of cancer biomarkers[J]. Lingnan Modern Clinics in Surgery, 2015, 15(06): 743-748.

参考文献

[1] Djebali S, Davis C A, Merkel A, et al. Landscape of transcription in human cells[J]. Nature. 2012, 489(7414): 101-108.
[2] Ponting C P, Belgard T G. Transcribed dark matter: meaning or myth?[J]. Hum Mol Genet. 2010, 19(R2): R162-R168.
[3] Wang K C, Chang H Y. Molecular mechanisms of long noncoding RNAs[J]. Mol Cell. 2011, 43(6): 904-914.
[4] Sun M, Gadad S S, Kim D S, et al. Discovery, Annotation, and Functional Analysis of Long Noncoding RNAs Controlling Cell-Cycle Gene Expression and Proliferation in Breast Cancer Cells[J]. Mol Cell. 2015.
[5] Chujo T, Yamazaki T, Hirose T. Architectural RNAs (arcRNAs): A class of long noncoding RNAs that function as the scaffold of nuclear bodies[J]. Biochim Biophys Acta. 2015.
[6] Liu B, Sun L, Liu Q, et al. A cytoplasmic NF-kappaB interacting long noncoding RNA blocks IkappaB phosphorylation and suppresses breast cancer metastasis[J]. Cancer Cell. 2015, 27(3): 370-381.
[7] Wang P, Xue Y, Han Y, et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation[J]. Science. 2014, 344(6181): 310-313.
[8] Wan L B, Bartolomei M S. Regulation of imprinting in clusters: noncoding RNAs versus insulators[J]. Adv Genet. 2008, 61: 207-223.
[9] Monnier P, Martinet C, Pontis J, et al. H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1[J]. Proc Natl Acad Sci U S A. 2013, 110(51): 20693-20698.
[10] Penny G D, Kay G F, Sheardown S A, et al. Requirement for Xist in X chromosome inactivation[J]. Nature. 1996, 379(6561): 131-137.
[11] Mchugh C A, Chen C, Chow A, et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3[J]. Nature. 2015, 521(7551): 232-236.
[12] Rinn J L, Kertesz M, Wang J K, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs[J]. Cell. 2007, 129(7): 1311-1323.
[13] Tsai M C, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes[J]. Science. 2010, 329(5992): 689-693.
[14] Lee J T, Davidow L S, Warshawsky D. Tsix, a gene antisense to Xist at the X-inactivation centre[J]. Nat Genet. 1999, 21(4): 400-404.
[15] Navarro P, Pichard S, Ciaudo C, et al. Tsix transcription across the Xist gene alters chromatin conformation without affecting Xist transcription: implications for X-chromosome inactivation[J]. Genes Dev. 2005, 19(12): 1474-1484.
[16] Tian D, Sun S, Lee J T. The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation[J]. Cell. 2010, 143(3): 390-403.
[17] Vance K W, Sansom S N, Lee S, et al. The long non-coding RNA Paupar regulates the expression of both local and distal genes[J]. EMBO J. 2014, 33(4): 296-311.
[18] Yoon J H, Abdelmohsen K, Srikantan S, et al. LincRNA-p21 suppresses target mRNA translation[J]. Mol Cell. 2012, 47(4): 648-655.
[19] Carrieri C, Cimatti L, Biagioli M, et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat[J]. Nature. 2012, 491(7424): 454-457.
[20] Tripathi V, Ellis J D, Shen Z, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation[J]. Mol Cell. 2010, 39(6): 925-938.
[21] Gutschner T, Hammerle M, Eissmann M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells[J]. Cancer Res. 2013, 73(3): 1180-1189.
[22] Fang X Y, Pan H F, Leng R X, et al. Long noncoding RNAs: novel insights into gastric cancer[J]. Cancer Lett. 2015, 356(2 Pt B): 357-366.
[23] Bolton E M, Tuzova A V, Walsh A L, et al. Noncoding RNAs in prostate cancer: the long and the short of it[J]. Clin Cancer Res. 2014, 20(1): 35-43.
[24] Yarmishyn A A, Kurochkin I V. Long noncoding RNAs: a potential novel class of cancer biomarkers[J]. Front Genet. 2015, 6: 145.
[25] Gupta R A, Shah N, Wang K C, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis[J]. Nature. 2010, 464(7291): 1071-1076.
[26] Fu W M, Zhu X, Wang W M, et al. Hotair Mediates Hepatocarcinogenesis through Suppressing MiRNA-218 Expression and Activating P14 and P16 Signaling[J]. J Hepatol. 2015.
[27] Zhang Z Z, Shen Z Y, Shen Y Y, et al. HOTAIR Long Noncoding RNA Promotes Gastric Cancer Metastasis through Suppression of Poly r(C)-Binding Protein (PCBP) 1[J]. Mol Cancer Ther. 2015, 14(5): 1162-1170.
[28] Kogo R, Shimamura T, Mimori K, et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers[J]. Cancer Res. 2011, 71(20): 6320-6326.
[29] Kim K, Jutooru I, Chadalapaka G, et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer[J]. Oncogene. 2013, 32(13): 1616-1625.
[30] Wang J, Chen D, He X, et al. Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition[J]. Cancer Cell Int. 2015, 15: 24.
[31] Wang B, Su Y, Yang Q, et al. Overexpression of Long Non-Coding RNA HOTAIR Promotes Tumor Growth and Metastasis in Human Osteosarcoma[J]. Mol Cells. 2015, 38(5): 432-440.
[32] Zhang S, Chen S, Yang G, et al. Long noncoding RNA HOTAIR as an independent prognostic marker in cancer: a meta-analysis[J]. PLoS One. 2014, 9(8): e105538.
[33] Padua A C, Fonseca A S, Muys B R, et al. Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines[J]. Stem Cells. 2013, 31(12): 2827-2832.
[34] Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer[J]. Oncogene. 2003, 22(39): 8031-8041.
[35] Hu L, Wu Y, Tan D, et al. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma[J]. J Exp Clin Cancer Res. 2015, 34: 7.
[36] Yang M H, Hu Z Y, Xu C, et al. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9[J]. Biochim Biophys Acta. 2015, 1852(1): 166-174.
[37] Pang E J, Yang R, Fu X B, et al. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer[J]. Tumour Biol. 2015, 36(4): 2403-2407.
[38] Wu X S, Wang X A, Wu W G, et al. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway[J]. Cancer Biol Ther. 2014, 15(6): 806-814.
[39] Han Y, Liu Y, Nie L, et al. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder[J]. Urology. 2013, 81(1): 201-209.
[40] Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development[J]. Bioessays. 2010, 32(6): 473-480.
[41] Matouk I J, Mezan S, Mizrahi A, et al. The oncofetal H19 RNA connection: hypoxia, p53 and cancer[J]. Biochim Biophys Acta. 2010, 1803(4): 443-451.
[42] Matouk I J, Halle D, Gilon M, et al. The non-coding RNAs of the H19-IGF2 imprinted loci: a focus on biological roles and therapeutic potential in Lung Cancer[J]. J Transl Med. 2015, 13: 113.
[43] Sun H, Wang G, Peng Y, et al. H19 lncRNA mediates 17beta-estradiol-induced cell proliferation in MCF-7 breast cancer cells[J]. Oncol Rep. 2015, 33(6): 3045-3052.
[44] Huang C, Cao L, Qiu L, et al. Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer[J]. Oncol Lett. 2015, 10(1): 291-296.
[45] Zhou X, Yin C, Dang Y, et al. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer[J]. Sci Rep. 2015, 5: 11516.
[46] Liu C, Chen Z, Fang J, et al. H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation[J]. Tumour Biol. 2015.
[47] Tsang W P, Ng E K, Ng S S, et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer[J]. Carcinogenesis. 2010, 31(3): 350-358.
[48] Zhang X, Zhou Y, Mehta K R, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells[J]. J Clin Endocrinol Metab. 2003, 88(11): 5119-5126.
[49] Ying L, Huang Y, Chen H, et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer[J]. Mol Biosyst. 2013, 9(3): 407-411.
[50] Lu K H, Li W, Liu X H, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression[J]. BMC Cancer. 2013, 13: 461.
[51] Sun M, Xia R, Jin F, et al. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer[J]. Tumour Biol. 2014, 35(2): 1065-1073.
[52] Yin D D, Liu Z J, Zhang E, et al. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer[J]. Tumour Biol. 2015.
[53] Kino T, Hurt D E, Ichijo T, et al. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor[J]. Sci Signal. 2010, 3(107): a8.
[54] Pickard M R, Williams G T. Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy[J]. Breast Cancer Res Treat. 2014, 145(2): 359-370.
[55] Shi X, Sun M, Liu H, et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer[J]. Mol Carcinog. 2015, 54 Suppl 1: E1-E12.
[56] Sun M, Jin F Y, Xia R, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer[J]. BMC Cancer. 2014, 14: 319.
[57] Tao R, Hu S, Wang S, et al. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma[J]. Carcinogenesis. 2015.
[58] Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response[J]. Cell. 2010, 142(3): 409-419.
[59] Yu M, Ohira M, Li Y, et al. High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma[J]. Int J Oncol. 2009, 34(4): 931-938.
[60] Zhu Y, Yu M, Li Z, et al. ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival[J]. Urology. 2011, 77(2): 510-511.
[61] Qi P, Xu M D, Ni S J, et al. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients[J]. Mol Carcinog. 2015, 54(9): 742-750.
[62] Lee G L, Dobi A, Srivastava S. Prostate cancer: diagnostic performance of the PCA3 urine test[J]. Nat Rev Urol. 2011, 8(3): 123-124.
[63] Walsh A L, Tuzova A V, Bolton E M, et al. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?[J]. Trends Mol Med. 2014, 20(8): 428-436.
[64] Ifere G O, Ananaba G A. Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression[J]. Recent Pat DNA Gene Seq. 2009, 3(3): 151-163.
[65] Chung S, Nakagawa H, Uemura M, et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility[J]. Cancer Sci. 2011, 102(1): 245-252.
[66] Matouk I J, Abbasi I, Hochberg A, et al. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis[J]. Eur J Gastroenterol Hepatol. 2009, 21(6): 688-692.
[67] Shao Y, Ye M, Jiang X, et al. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer[J]. Cancer. 2014, 120(21): 3320-3328.
[68] Weber D G, Johnen G, Casjens S, et al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer[J]. BMC Res Notes. 2013, 6: 518.